Trilobio Unveils Revolutionary Whole-Lab Automation Platform at SLAS2025: A Game-Changer for Life Science Research
San Diego, CA – January 25-29, 2025 – Trilobio, a pioneering developer of whole-laboratory automation solutions, is set to make waves at the Society for Laboratory Automation and Screening (SLAS2025) conference with the first public demonstration of its unified robotics, device, and software platform. Attendees can experience this groundbreaking innovation at Booth 2115, where Trilobio will showcase its cutting-edge technology designed to transform genetic engineering, synthetic biology, and life science research.
Pilot programs conducted at leading biology labs have already demonstrated the platform’s exceptional capabilities, reporting a 33% increase in throughput and a 25% boost in data production compared to traditional workflows. These results underscore Trilobio’s mission to address critical challenges in research reproducibility, efficiency, and scalability.
A Platform Built by Biologists, for Biologists
Trilobio was founded in 2021 by Roya Amini-Naieni and Maximilian Schommer, both recognized on Forbes’ 30 Under 30 list for their contributions to manufacturing and industry. The company was born out of a need to overcome the inefficiencies plaguing life science research. Despite advancements in laboratory automation, an estimated 77% of biologists struggle to reproduce their own or others’ research. Trilobio’s platform aims to bridge this gap by integrating robotics, lab equipment, and software into a seamless, user-friendly system.
“Our platform is built by biologists for biologists,” said Roya Amini-Naieni, CEO and Co-founder of Trilobio. “We’ve designed it with the understanding that full integration and automation can unlock the full potential of research. With Trilobio, biologists can start using our robots within 30 minutes of unboxing, design research protocols in minutes instead of days, and access these capabilities at an affordable price.”
The Trilobio Platform: A Comprehensive Solution
The Trilobio platform consists of three core components:
- Trilobot: A multifunctional lab robot built on standardized hardware and software, capable of operating any Trilobio research tool and collaborating with other Trilobots to scale research operations.
- Research Devices: Including grippers, pipettes, and tube handlers, these tools are designed to integrate seamlessly with the Trilobot.
- Trilobio OS: A powerful software engine that combines protocol design, optimization, and execution with an automated lab notebook and LIMS (Laboratory Information Management System).
Trilobio OS is particularly revolutionary, enabling biologists to design advanced research protocols through a no-code graphical user interface (GUI). This eliminates the need for machine code expertise, making automation accessible to a broader range of scientists. The software also allows users to optimize protocols for speed, cost, or accuracy, ensuring maximum efficiency.
Pilot Program Success Stories
It’s platform has already been deployed in several leading biology labs, generating impressive results:
- Leconte Group (Claremont Colleges): Aaron Leconte, Associate Professor of Chemistry, praised the Trilobot for its reliability and ease of use. “The Trilobot is the first low-cost automation system where I could genuinely see giving over more experimental responsibility to the robot. It’s more reliable than other systems, and we haven’t had to deal with common issues like dropped pipette tips or delivery errors.”
- Abalone Bio: Monica Schwartz, VP of Antibody Discovery, highlighted the platform’s impact on reducing human error and increasing throughput. “With the Trilobot executing our assays, we’ve achieved higher consistency and accuracy. It ensures that cultures are moved to the correct well and the correct pipette volume every time. This has increased our testing throughput by 33%.”
- Triton Bio: Lorenzo D’Amico, CEO and Founder, emphasized the time-saving benefits of the platform. “We’ve saved 80 hours of training time for new employees and freed up our technician to focus on other tasks. Data production has increased by around 25%, and the Trilobot offers true walk-away automation.”
Overcoming Barriers to Automation Adoption
One of Trilobio’s key goals is to address the cost, complexity, and training hurdles that have historically prevented widespread adoption of lab automation. By offering an affordable, user-friendly platform, Trilobio is democratizing access to advanced research tools.
The company has raised $3 million in a pre-seed funding round led by Argon Ventures and Lowercarbon Capital, enabling it to accelerate the development and deployment of its platform.
A Vision for the Future of Life Science Research
It’s platform is not just a tool; it’s a vision for the future of life science research. By automating entire lab operations, the company aims to empower biologists to focus on innovation rather than repetitive tasks. The platform’s ability to ensure reproducibility across labs is a significant step toward addressing the reproducibility crisis in scientific research.
As Trilobio takes center stage at SLAS2025, the life science community is poised to witness a transformative shift in how research is conducted. With its innovative approach to automation, Trilobio is paving the way for faster, more accurate, and more reliable scientific discoveries.
Visit Trilobio at Booth 2115 during SLAS2025 to experience the future of lab automation firsthand.
Read more: Trilobio Unveils Groundbreaking Whole-Laboratory Automation Platform at SLAS2025
